Cognoa Overview

  • Founded
  • 2013
  • Status
  • Private
  • Employees
  • 67
  • Latest Deal Type
  • Series A
  • Latest Deal Amount
  • $42.7M
Latest Deal Amount
  • Investors
  • 2

Cognoa General Information


Developer of digital diagnostic and therapeutic solutions designed to enable earlier diagnosis and treatment of behavioral health conditions, such as autism. The company's AI technology platform enables Cognoa's product pipeline to address additional unmet needs including ADHD and anxiety. Cognoa plans to commercialize its first product, the first digital autism diagnosis aid, under the name Canvas Dx™ and expects to begin making Canvas Dx™ available in the U.S. later in 2021.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Healthcare Technology Systems
Other Industries
Other Healthcare Services
Primary Office
  • Care Of Wilson Sonsini Goodrich & Rosati
  • P.C., 650 Page Mill Road
  • Palo Alto, CA 94304-1050
  • United States
+1 (650) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Cognoa Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC (Series A) 08-Oct-2019 $42.7M 000.00 000.00 Completed Generating Revenue
3. Early Stage VC (Series A) 28-Mar-2017 000.00 000.00 000.00 Completed Generating Revenue
2. Early Stage VC (Series A) 10-Nov-2016 $3.82M $8.82M 000.00 Completed Product Development
1. Early Stage VC (Series A) 01-Sep-2013 $5M $5M 000.00 Completed Startup
To view Cognoa’s complete valuation and funding history, request access »

Cognoa Cap Table

Stock # of Shares
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A 00,000,000 00.000000 00 00 00 00 00 00.000
To view Cognoa’s complete cap table history, request access »

Cognoa Executive Team (13)

Name Title Board Seat Contact Info
David Happel Chief Executive Officer & President
Elizabeth Rozek JD Chief Compliance Officer & General Counsel
Halim Abbas Chief AI Officer
Eric Chen Vice President & Head of Finance and Program Management
Sharief Taraman MD Chief Medical Officer
You’re viewing 5 of 13 executive team members. Get the full list »

Cognoa Board Members (1)

Name Representing Role Since
Reenie McCarthy JD Self Chairman 000 0000
To view Cognoa’s complete board members history, request access »

Cognoa Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cognoa Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Social Innovation Ventures Venture Capital Minority 000 0000 000000 0
Morningside Group Venture Capital Minority 000 0000 000000 0
To view Cognoa’s complete investors history, request access »